SIO GENE THERAPIES INC's ticker is and the CUSIP is 829399904. A total of 3 filers reported holding SIO GENE THERAPIES INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,000 | 0.0% | 2,300 | -36.1% | 0.00% | – |
| Q2 2022 | $1,000 | -93.3% | 3,600 | -83.9% | 0.00% | – |
| Q1 2022 | $15,000 | -81.5% | 22,400 | -64.2% | 0.00% | – |
| Q4 2021 | $81,000 | -56.5% | 62,500 | -26.9% | 0.00% | – |
| Q3 2021 | $186,000 | -15.5% | 85,500 | +5.9% | 0.00% | – |
| Q2 2021 | $220,000 | +209.9% | 80,700 | +197.8% | 0.00% | – |
| Q1 2021 | $71,000 | -91.5% | 27,100 | -91.0% | 0.00% | -100.0% |
| Q4 2020 | $833,000 | – | 299,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 85,500 | $186,000 | 0.00% |
| SIMPLEX TRADING, LLC | 17,300 | $46,000 | 0.00% |